DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Oglemilast is an investigational drug.
There have been 4 clinical trials for Oglemilast. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Asthma, Lung Diseases, and Chronic Disease. The leading clinical trial sponsors are Forest Laboratories, Glenmark Pharmaceuticals Europe Ltd. (R&D), and [disabled in preview].
Recent Clinical Trials for Oglemilast
|A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma||Glenmark Pharmaceuticals Europe Ltd. (R&D)||Phase 2|
|Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)||Forest Laboratories||Phase 2|
|Study of Oglemilast for the Prevention of Asthma.||Forest Laboratories||Phase 2|